Lantern Pharma Inc share price logo

Lantern Pharma Inc Share Price

NASDAQ: LTRN

Small Cap

$4.02

+0.11

(+2.81%)

Live

as on

Lantern Pharma Inc Stock Performance

as on September 18, 2025 at 8:36 pm IST

  • Day's Low

    Day's High

    $3.89
    $4.13
    downward going graph

    3.23%

    Downside

    2.74%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $2.55
    $6.12
    downward going graph

    36.57%

    Downside

    52.19%

    Upside

    downward going graph

Lantern Pharma Inc share price movements today

Previous Close
$3.91
Open
$3.91
Volume
46.5K
Day's Low - High
$3.89 - $4.13
52 Week Low - High
$2.55 - $6.12

Lantern Pharma Inc Historical Returns

1 Month Return
-11.94 %
3 Month Return
+ 22.96 %
1 Year Return
0 %
3 Year Return
-21.96 %
5 Year Return
-76.26 %

Lantern Pharma Inc Stock Fundamentals & Key Indicators

Check Lantern Pharma Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$42.2M

EPS (TTM)

-1.83

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

P/B Ratio

0

PEG Ratio

0

EBITDA

-20.5M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

74638100.00%

Lantern Pharma Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Lantern Pharma Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$42.2M-76.26%NA0.00%
BUY$60.5B241.54%-505.15-12.96%
NA$38.7BNANA-3.89%
BUY$99.3B45.88%27.5631.86%
BUY$60.9B5.45%14.4931.37%

Stock Returns calculator for Lantern Pharma Inc Stock including INR - Dollar returns

The Lantern Pharma Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Lantern Pharma Inc investment value today

Current value as on today

₹1,07,767

Returns

₹7,767

(+7.77%)

Returns from Lantern Pharma Inc Stock

₹2,813 (+2.81%)

Dollar Returns*

₹4,953 (+4.95%)

Analyst Recommendation on Lantern Pharma Inc Stock

Based on 8 analysts

BUY

75.00%

Buy

25.00%

Hold

0.00%

Sell

Based on 8 analysts, 75% of analysts recommend a 'BUY' rating for Lantern Pharma Inc. Average target price of $22

Lantern Pharma Inc Share Price Target

Get share price movements and forecasts by analysts on Lantern Pharma Inc.

What analysts predicted

81.73%UPSIDE

Target Price

$22

Current Price

$4.02

Analyzed by

8 Analysts

Target

$22.00

Lantern Pharma Inc target price $22, a slight upside of 81.73% compared to current price of $4.02. According to 8 analysts rating.

Lantern Pharma Inc Stock's Interest Amongst Investors

Search interest for Lantern Pharma Inc Stock has decreased by -33% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-33% versus previous 30 day period

Lantern Pharma Inc Quarterly Profit & Loss

All numbers in Millions USD

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Total Revenue
-
-
-
0
-
-
-
0
0
-
Gross Profit
0
0
0
0
0
0
0
0
0
0
Operating Income
-4
-5
-3
-4
-5
-5
-5
-5
-4
-4
EBITDA
-4
-5
-3
-4
-5
-5
-5
-5
-4
-4
Interest Expense
0
-
-
0
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-3
-4
-3
-4
-5
-4
-4
-5
-4
-4
Income Tax Expense
0
0
0
0
0
0
-
-
0
-
Net Income
-3
-4
-3
-4
-5
-4
-4
-5
-4
-4
Net Profit Margin
0.00%
0.00%
0.00%
-1603.48%
0.00%
0.00%
0.00%
-5837.03%
-4507.31%
0.00%

Lantern Pharma Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
-
-
-
-
-
-
-
Gross Profit
0
0
0
0
0
0
0
Operating Income
-1
-2
-5
-12
-14
-17
-22
EBITDA
-1
-2
-5
-12
-14
-15
-20
Interest Expense
-
-
-
0
0
-
-
Depreciation
0
0
0
0
0
0
0
Income Before Tax
-1
-2
-5
-12
-14
-15
-20
Income Tax Expense
0
0
0
0
0
0
-
Net Income
-1
-2
-5
-12
-14
-15
-20
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Lantern Pharma Inc Quarterly Cash Flow

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Net Income
-4
-3
-4
-5
-4
-4
-5
-4
-4
Operating Cash Flow
-3
-3
-3
-3
-5
-5
-3
-4
-3
Investing Cash Flow
0
0
0
0
0
0
3
3
3
Financing Cash Flow
0
-
0
0
-
0
-
66
-
Change in Cash
-4
-3
-3
-3
-5
-4
0
-1
0

Lantern Pharma Inc Annual Cash Flow

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
-2
-5
-12
-14
-15
-20
Operating Cash Flow
-2
-5
-10
-12
-14
-17
Investing Cash Flow
0
0
-19
0
0
3
Financing Cash Flow
2
23
63
-2
0
0
Change in Cash
0
17
33
-13
-15
-14

Global Institutional Holdings in Lantern Pharma Inc

Funds
Holdings
BIOS CAPITAL MANAGEMENT, LP
11.2%
Vanguard Group Inc
3.37%
CM Management, LLC
1.85%
Geode Capital Management, LLC
0.84%
Renaissance Technologies Corp
0.82%

Insights on Lantern Pharma Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 111.5% return, outperforming this stock by 133.5%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Beone Medicines Ltd has given 68.4% return, outperforming this stock by 68.4%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 month, LTRN stock has moved down by -11.9%

About Lantern Pharma Inc

lantern pharma is leading a wave of innovation in cancer treatment that we believe will bring the best therapies to patients who are most likely to respond. we are pioneering precision medicine approach to cancer by tailoring promising drug programs to the right patients. our approach is to use biomarker based genetic screening to identify and treat patients that would benefit most from our drugs. we believe this approach will reduce the cost of development and increase the speed to market. our strategy is to acquire or partner with promising drug and diagnostic companies to move forward promising personalized medicine programs for cancer patients.
OrganisationLantern Pharma Inc
Headquarters1920 McKinney Avenue, Dallas, TX, United States, 75201
IndustryCommercial Services
CEOMr. Panna Sharma
E-voting on sharesClick here to vote

Key Management of Lantern Pharma Inc

Name

Title

Dr. Kishor Gopaldas Bhatia Ph.D.

Chief Scientific Officer & Scientific Consultant

Dr. Peter L. Nara D.V.M., M.S., Ph.D.

Co-Founder & Advisor

Mr. Ernest Kitt B.S., M.S

Head of Clinical Operations

Dr. Marc C. Chamberlain M.D.

Chief Medical Officer of Starlight Therapeutics

Mr. Panna Sharma

President, CEO & Director

Mr. David R. Margrave

CFO & Secretary

FAQs

What is Lantern Pharma Inc share price today?

Lantern Pharma Inc share price today is $4.02 as on . Lantern Pharma Inc share today touched a day high of $4.13 and a low of $3.89.

What is the 52 week high and 52 week low for Lantern Pharma Inc share?

Lantern Pharma Inc share touched a 52 week high of $6.12 on and a 52 week low of $2.55 on . Lantern Pharma Inc stock price today i.e. is trending at $4.02,which is 34.29% down from its 52 week high and 57.65% up from its 52 week low.

What is Lantern Pharma Inc's market capitalisation today?

Lantern Pharma Inc market capitalisation is $0.00T as on .

How to invest in Lantern Pharma Inc Stock (LTRN) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Lantern Pharma Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Lantern Pharma Inc Shares that will get you 0.3731 shares as per Lantern Pharma Inc share price of $4.02 per share as on September 18, 2025 at 8:36 pm IST.

What is the minimum amount required to buy Lantern Pharma Inc Stock (LTRN) from India?

Indian investors can start investing in Lantern Pharma Inc (LTRN) shares with as little as ₹88.114 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹881.14 in Lantern Pharma Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Lantern Pharma Inc share’s latest price of $4.02 as on September 18, 2025 at 8:36 pm IST, you will get 2.4876 shares of Lantern Pharma Inc. Learn more about fractional shares .

What are the returns that Lantern Pharma Inc has given to Indian investors in the last 5 years?

Lantern Pharma Inc stock has given -76.26% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?